BenevolentAI SA
BenevolentAI S.A. operates as a clinical-stage artificial intelligence (AI) enabled drug discovery and development company. Its Benevolent platform integrates AI and science to uncover and develop drugs for complex diseases. The company's development pipeline includes BEN-8744, an oral phosphodiesterase 10 (PDE10) inhibitor under phase 1 study for the treatment of Ulcerative Colitis; BEN-28010, a… Read more
Market Cap & Net Worth: BenevolentAI SA (BAI)
BenevolentAI SA (AS:BAI) has a market capitalization of $10.14 Million (€9.88 Million) as of March 18, 2026. Listed on the AS stock exchange, this Netherlands-based company holds position #28745 globally and #45 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying BenevolentAI SA's stock price €0.08 by its total outstanding shares 121940000 (121.94 Million).
BenevolentAI SA Market Cap History: 2021 to 2025
BenevolentAI SA's market capitalization history from 2021 to 2025. Data shows change from $1.24 Billion to $10.14 Million (-72.78% CAGR).
BenevolentAI SA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how BenevolentAI SA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
18.44x
BenevolentAI SA's market cap is 18.44 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $1.24 Billion | $4.62 Million | -$86.48 Million | 268.60x | N/A |
| 2022 | $438.09 Million | $10.56 Million | -$163.93 Million | 41.49x | N/A |
| 2023 | $135.18 Million | $7.33 Million | -$63.32 Million | 18.44x | N/A |
Competitor Companies of BAI by Market Capitalization
Companies near BenevolentAI SA in the global market cap rankings as of March 18, 2026.
Key companies related to BenevolentAI SA by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
BenevolentAI SA Historical Marketcap From 2021 to 2025
Between 2021 and today, BenevolentAI SA's market cap moved from $1.24 Billion to $ 10.14 Million, with a yearly change of -72.78%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | €10.14 Million | -78.68% |
| 2024 | €47.56 Million | -64.81% |
| 2023 | €135.18 Million | -69.14% |
| 2022 | €438.09 Million | -64.74% |
| 2021 | €1.24 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 12th, 2026 the market cap of BenevolentAI SA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $10.14 Million USD |
| MoneyControl | $10.14 Million USD |
| MarketWatch | $10.14 Million USD |
| marketcap.company | $10.14 Million USD |
| Reuters | $10.14 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.